Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Gerard Prinz Insider Profile
4 Followers
John Gerard Prinz, Director at Optima Medical Innovations, holds 1.40M shares in Optima Medical Innovations (Ticker: TOKIF). Most recently, John Gerard Prinz ― shares of Optima Medical Innovations on ― for an estimated value of ―.
John Gerard Prinz has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of John Gerard Prinz's holdings
Insider Roles
Director
Roles that John Gerard Prinz holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by John Gerard Prinz
John Gerard Prinz's Trading History
List of latest transactions for each holding click on a transaction to see John Gerard Prinz's performance on stock
You May Also Like
John Gerard Prinz insider profile FAQ
What is the percentage of profitable transactions made by John Gerard Prinz?
The percentage of profitable transactions made by John Gerard Prinz is ―.
What is the average return per transaction made by John Gerard Prinz?
The average return per transaction made by John Gerard Prinz is ―.
What stocks does John Gerard Prinz hold?
John Gerard Prinz holds: TOKIF stocks.
What was John Gerard Prinz’s latest transaction?
John Gerard Prinz latest transaction was an Uninformative Buy of ―.
What was John Gerard Prinz's most profitable transaction?
John Gerard Prinz’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is John Gerard Prinz's role in Optima Medical Innovations?
John Gerard Prinz's role in Optima Medical Innovations is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.